Newborn screening for rare hormone disorder put to the test
NCT ID NCT06728748
First seen Apr 04, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study reviewed medical records of 29 newborns in Italy to see how effective routine screening is for congenital adrenal hyperplasia (CAH), a hormone disorder. Researchers measured how many cases were found and how accurate the screening test was. The goal was to understand the real-world impact of screening on early diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino, Torino, 10123, Italy
-
Azienda Ospedaliera Universitaria Integrata Verona:
Verona, Verona, 37126, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
-
IRCCS Ospedale San Raffaele
Milan, Milano, 20132, Italy
Conditions
Explore the condition pages connected to this study.